Has Ned Nafziger received payments from drug or device companies?

Yes. Drug and device makers reported $8,097 in general payments to Ned Nafziger across 436 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Ned Nafziger did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Ned Nafziger come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Ned Nafziger

Physical Medicine & Rehabilitation · Canton, OHNPI 1538109426

Payments from drug & device makers

$8,097in general payments, 2019–2025

Across 436 payments — averaging $18.57 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

AbbVie$833
UCB, Inc.$792
SK Life Science, Inc.$561
E.r. Squibb & Sons, L.L.C.$500
Amgen$486
Harmony Biosciences LLC$336
plus $5K from 51 others

What the payments were for

Food & beverage$8,02099%
Education$771%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
AbbVie(2 entities)	67	$833
UCB, Inc.	31	$792
SK Life Science, Inc.	29	$561
E.r. Squibb & Sons, L.L.C.	7	$500
Amgen(2 entities)	30	$486
Harmony Biosciences LLC	21	$336
Jazz Pharmaceuticals Inc.	19	$304
Eisai Inc.	15	$277
Lilly USA, LLC	16	$268
Johnson & Johnson(2 entities)	10	$256
Neurocrine Biosciences, Inc.	15	$249
Lundbeck LLC	11	$229
AstraZeneca	8	$214
EMD Serono, Inc.	10	$185
Sumitomo Pharma America, Inc.	15	$165
Novartis	9	$156
Acadia Pharmaceuticals Inc	8	$153
Avadel CNS Pharmaceuticals, LLC	7	$151
Axsome Therapeutics, Inc.	7	$149
Kyowa Kirin, Inc.	8	$148
Amneal Pharmaceuticals LLC	7	$129
Teva Pharmaceuticals USA, Inc.	9	$123
Sanofi	7	$118
Biohaven Pharmaceuticals, Inc.	6	$116
Vanda Pharmaceuticals Inc.	4	$98
Genentech USA, Inc.	5	$78
Supernus Pharmaceuticals, Inc.	3	$74
Xeris Pharmaceuticals, Inc.	4	$68
TG Therapeutics, Inc.	3	$64
Acorda Therapeutics, Inc	4	$63
Upsher-smith Laboratories LLC	3	$62
Argenx US, Inc.	2	$56
Impel Pharmaceuticals LLC	2	$45
GE HealthCare	3	$42
Neurelis, Inc.	3	$42
Merck	2	$40
Avanir Pharmaceuticals, Inc.	2	$34
Biohaven Pharmaceutical Holding Company Ltd.	2	$34
Mallinckrodt Hospital Products Inc.	2	$32
Corium, LLC	1	$31
Takeda Pharmaceuticals U.S.A., Inc.	1	$29
Collegium Pharmaceutical, Inc.	2	$29
Otsuka America Pharmaceutical, Inc.	2	$27
Impel Pharmaceuticals Inc.	1	$25
Otsuka Pharmaceutical Development & Commercialization, Inc.	1	$24
Sunovion Pharmaceuticals Inc.	1	$22
Bristol Myers Squibb	1	$21
Grifols USA, LLC	1	$20
Aquestive Therapeutics, Inc.	1	$18
Scilex Pharmaceuticals Inc.	1	$17
Biogen	1	$17
Cycle Pharmaceuticals Inc	1	$16
Vertical Pharmaceuticals, LLC	1	$16
Pfizer	1	$14
Avion Pharmaceuticals	1	$14
Cala Health, Inc.	1	$14
Tanabe Pharma America, Inc.	1	$12

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

ZEPOSIA$230

How this compares

$8,097 in reported general payments places this provider in the 90th percentile of 332 physical medicine & rehabilitation providers in Ohio.

See all physical medicine & rehabilitation providers in Ohio →

Medicare billing

Part B allowed, 2024

$152,914

Medicare patients

172

Services billed

10,790

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Baclofen	56	$587
Gabapentin	24	$261
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen	25	$234
Tizanidine Hcl	13	$80
Tramadol Hcl	18	$79

Paid to pharmacies, not to this prescriber.

Other physical medicine & rehabilitation in Canton

Francois BethouxCleveland$216K
Michael BariaLewis Center$185K
Kathryn MosherAkron$139K
Marc OrlandoCincinnati$114K
James BeeganCenterville$96K
Shahla HosseiniWest Chester$85K
Eric MayerCleveland$81K
Richard WilsonCleveland$80K
Aileen PadillaPerrysburg$73K
Jeffrey StrakowskiColumbus$59K

See the full list for Ohio →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →